GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca

GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a ‘bidding war.’ Luke added that GSK is looking to acquire or partner with biotechs’ hiding in plain sight’ to expand its pipeline. Earlier this year, GSK acquired Sierra Oncology for $55 […]

Bloomberg Shows Acquisition Interest in Dow Jones, Washington Post

Media tycoon Michael Bloomberg has reportedly shown interest in acquiring either Wall Street Journal’s parent company, Dow Jones, or The Washington Post as he finds Dow Jones an ideal fit for expanding the media business. He is also targeting the Washington Post if Jeff Bezos is ready to sell it, which he acquired in 2013 … […]

Netflix Said To Be On Acquisition Radar Of This Tech Giant

Netflix Inc. (NASDAQ: NFLX) has shed over 52% for the year-to-date period even as the company has embarked on a turnaround plan following a massive loss of net paid subscribers earlier this year. A report explored the possibility of the streaming giant being an object of interest to another large-cap tech company. What Happened: Software giant […]

On A Mission As Top European Player, Galapagos Looks For Acquisition Targets

Galapagos NV (NASDAQ: GLPG) is reportedly looking for M&A deals with companies with products still in the preclinical or early stage of development. The former chief scientific officer of Johnson & Johnson (NYSE: JNJ) took the reins at the struggling Belgian biotech this year. Paul Stoffels is on a “mission,” Financial Times reported, to reinstate Galapagos as a top […]

EXCLUSIVE: The Psychedelics Debate Is ‘Raging’ As Filament Debuts Ayahuasca Pill

Part two of a three-part series. Previous story: Standardized Ayahuasca Pill Is Officially Here, Feast Yourself With The Exclusive Details & Insights When it comes to the ayahuasca pill, Filament Health (OTCMTKS: FLHLF) CEO Ben Lightburn says the product won’t just be for the pharmaceutical market. “Maybe the pharma market will be a relatively small […]

Lockheed Martin, Boeing Among US Defense Companies In Potential Talks For Military Gear For Vietnam

In a bid to reduce its dependence on Russian arms, some Vietnam government officials and U.S. defense firms are reportedly discussing the supply of military gear. The talks are preliminary and may not lead to any deals. Lockheed Martin Corp (NYSE: LMT), Boeing Co (NYSE: BA), Raytheon Technologies Corp (NYSE: RTX), Textron Inc (NYSE: TXT), and IM Systems Group met with the officials on […]

Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic’s Spun Off Units

Siemens Healthineers AG (OTC: SMMNY) (OTC: SEMHF) and General Electric Company’s (NYSE: GE) healthcare arm are reportedly weighing the potential acquisition of Medtronic Plc’s (NYSE: MDT) two businesses being spun-off. Medtronic announced in October its intention to spin off the Patient Monitoring and Respiratory Interventions units within the next year to 18 months.  Medtronic’s patient-monitoring and respiratory-intervention businesses are also … […]

CPI Data Leak? Traders Cry Foul Over Suspicious Market Action

The SPDR S&P 500 ETF Trust (NYSE: SPY) initially jumped more than 2.5% on Tuesday morning after the consumer price index inflation reading for November came in lower than expected. Yet the timing of the initial spike in the stock market has raised some eyebrows among seasoned traders. What Happened? About 60 seconds before the CPI […]

United Airlines And Boeing Poised To Ink Significant Order Agreement For 787s

United Airlines Holdings Inc (NASDAQ: UAL) plans to order Boeing Co’s (NYSE: BA) 787 Dreamliner next week, although the number of 787s United may order is unclear. Reuters reported that Boeing and United were close to reaching a deal last week. In August, United CEO Scott Kirby told pilots that the carrier plans to order more than 100 wide-body airplanes.  […]